A Meta-Analysis of Icodextrin versus Glucose Containing Peritoneal Dialysis in Metabolic Management of Peritoneal Dialysis Patients

被引:10
|
作者
He, Qiang [1 ]
Zhang, Wei [1 ]
Chen, Jianghua [1 ,2 ]
机构
[1] Zhejiang Univ, Kidney Dis Ctr, Affiliated Hosp 1, Coll Med, Hangzhou 310003, Zhejiang, Peoples R China
[2] Minist Publ Hlth, Key Lab Combined Multi Organ Transplantat, Hangzhou, Zhejiang, Peoples R China
关键词
peritoneal dialysis; icodextrin-based solutions; glucose-based solutions; fasting plasma glucose; meta-analysis; QUALITY; PARAMETERS; DWELL;
D O I
10.3109/0886022X.2011.615965
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Objectives: The objective of this article is to study the available works on comparison between icodextrin-based solutions (ICO) and glucose-based solutions (GLU) in peritoneal dialysis (PD) patients. The final aim was to get evidence for potential differences in metabolic management of PD patients by comparing the ICO with the GLU for the long dwell once a day. Methods: A meta-analysis of included reports, identified by MEDLINE and other sources, containing information on fasting plasma glucose, total cholesterol, triglycerides, and so on in PD patients, was performed. Results: Nine randomized controlled trials (RCTs) (553 patients) were included. The ICO did not differ from the GLU with respect to fasting plasma glucose (weighted mean difference (WMD) = -0.76; 95% confidence interval (CI) = -1.79 to 0.28; Z = 1.43; p = 0.15), triglycerides (WMD = -0.66; 95% CI = -1.40 to 0.09; Z = 1.73; p = 0.08), and body weight (WMD = -2.02; 95% CI = -5.06 to 1.03; Z = 1.30; p = 0.20). But peritoneal creatinine clearance (WMD = 0.49; 95% CI = 0.34-0.64; Z = 6.35; p < 0.00001), urea clearance (WMD = 0.40; 95% CI = 0.25-0.55; Z = 5.12; p < 0.00001), and plasma total cholesterol (WMD = -0.40; 95% CI = -0.70 to -0.10; Z = 2.64; p = 0.008) were higher for the ICO versus the GLU. Conclusions: The ICO had been shown to have significant advantages over the GLU in small solute clearance and plasma total cholesterol. Patients, no matter what kind of PD solution was used, had no significant difference of plasma triglycerides, fasting plasma glucose, and body weight.
引用
收藏
页码:943 / 948
页数:6
相关论文
共 50 条
  • [1] Gastric emptying in peritoneal dialysis patients: Glucose versus icodextrin.
    Schoonjans, R
    Van Vlem, B
    Van Biesen, W
    Vandamme, W
    Lameire, N
    [J]. GASTROENTEROLOGY, 2000, 118 (04) : A392 - A392
  • [2] Randomized Controlled Trial of Icodextrin versus Glucose Containing Peritoneal Dialysis Fluid
    Lin, Aiwu
    Qian, Jiaqi
    Li, Xiaomei
    Yu, Xueqing
    Liu, Wenhu
    Sun, Yang
    Chen, Nan
    Mei, Changlin
    [J]. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2009, 4 (11): : 1799 - 1804
  • [3] The role of icodextrin in peritoneal dialysis: protocol for a systematic review and meta-analysis
    Monika Becker
    Stefanie Bühn
    Jessica Breuing
    Catherine A. Firanek
    Simone Hess
    Hisanori Nariai
    Mark R. Marshall
    James A. Sloand
    Qiang Yao
    Käthe Goossen
    Dawid Pieper
    [J]. Systematic Reviews, 8
  • [4] The role of icodextrin in peritoneal dialysis: protocol for a systematic review and meta-analysis
    Becker, Monika
    Buhn, Stefanie
    Breuing, Jessica
    Firanek, Catherine A.
    Hess, Simone
    Nariai, Hisanori
    Marshall, Mark R.
    Sloand, James A.
    Yao, Qiang
    Goossen, Kathe
    Pieper, Dawid
    [J]. SYSTEMATIC REVIEWS, 2019, 8 (1)
  • [5] Biphasic Regulation of Lipid Metabolism: A Meta-Analysis of Icodextrin in Peritoneal Dialysis
    Huang, Yan-Feng
    Zhu, Da-Jian
    Chen, Xiao-Wu
    Ouyang, Man-Zhao
    Zhang, Wei-Jie
    [J]. BIOMED RESEARCH INTERNATIONAL, 2015, 2015
  • [6] Pharmacokinetics of icodextrin in peritoneal dialysis patients
    Moberly, JB
    Mujais, S
    Gehr, T
    Hamburger, R
    Sprague, S
    Kucharski, A
    Reynolds, R
    Ogrinc, F
    Martis, L
    Wolfson, M
    [J]. KIDNEY INTERNATIONAL, 2002, 62 : S23 - S33
  • [7] Overestimation of blood glucose due to peritoneal dialysis fluid containing icodextrin
    King, Daniel A.
    Ericson, Richard P.
    Todd, Nevins W.
    [J]. CHEST, 2007, 132 (04) : 696S - 697S
  • [8] ICODEXTRIN METABOLITES IN PERITONEAL DIALYSIS
    Garcia-Lopez, Elvia
    Lindholm, Bengt
    [J]. PERITONEAL DIALYSIS INTERNATIONAL, 2009, 29 (04): : 370 - 376
  • [9] Efficacy of icodextrin in automated peritoneal dialysis patients
    Tintillier, A
    Goffin, E
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2002, 40 (02) : 435 - 435
  • [10] Recommendations for the use of icodextrin in peritoneal dialysis patients
    Johnson, DW
    Agar, J
    Collins, J
    Disney, A
    Harris, DCH
    Ibels, L
    Irish, A
    Saltissi, D
    Suranyi, M
    [J]. NEPHROLOGY, 2003, 8 (01) : 1 - 7